文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全球、区域和国家胃食管反流病负担,1990-2019 年:来自 GBD 2019 研究的更新。

Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study.

机构信息

Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.

Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Changsha, China.

出版信息

Ann Med. 2022 Dec;54(1):1372-1384. doi: 10.1080/07853890.2022.2074535.


DOI:10.1080/07853890.2022.2074535
PMID:35579516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9122392/
Abstract

BACKGROUND: Because trends in the epidemiology and burden of gastroesophageal reflux disease (GERD) are changing, reinvestigating the geographical differences and trend changes is essential. Here we evaluated the latest epidemiologic patterns and trends for GERD, using data from Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. METHODS: Annual case numbers, age-standardized rates of prevalence, incidence, and years of life lived with disability (YLDs), and their estimated annual percentage changes (EAPCs) for GERD between 1990 and 2019 were derived from the GBD 2019 study. Association between GERD burden and socio-demographic index (SDI) was also investigated. RESULTS: In 2019, there were 783.95 million cases of GERD globally. Between 1990 and 2019, the total number of prevalent cases, incident cases, and YLDs increased by 77.53%, 74.79%, and 77.19%, respectively. The global age-standardized incidence rate (ASIR) and age-standardized YLD rate (ASYR) increased during this period (EAPC = 0.06 and 0.05, respectively). Tropical Latin America and East Asia had the highest and lowest age-standardiZed prevalence rate (ASPR), ASIR, and ASYR in 2019, respectively. From 1990 to 2019, prevalent cases, incident cases, YLDs, and their corresponding age-standardized rates of GERD were higher in females than males in all years. Higher SDI was associated with lower ASPR, ASIR, and ASYR of GERD in 2019. CONCLUSIONS: GERD will continue to be a major public health burden due to increasing numbers of prevalent cases, incident cases, and YLDs. In order to tackle this troublesome disease, it is crucial to understand the changes in both global and regional trends in epidemiology and the burden for policymakers and other stakeholders. Key messagesThis is the most updated estimate on GERD epidemiology globally, including 204 countries, some of which were not assessed before.The overall burden of GERD continued to worsen with the prevalent cases increasing by 77.53% from 441.57 million in 1990 to 783.95 million in 2019.GERD is likely to remain a common reason for consultation in primary care, and our data may allow for health service provision planning.

摘要

背景:由于胃食管反流病(GERD)的流行病学和负担趋势正在发生变化,因此重新调查地理差异和趋势变化至关重要。在这里,我们使用来自全球疾病、伤害和危险因素研究(GBD)2019 年的数据,评估了 GERD 的最新流行病学模式和趋势。

方法:从 GBD 2019 研究中得出了 1990 年至 2019 年期间 GERD 的年发病例数、年龄标准化患病率、发病率和残疾生活年(YLD)以及估计的年百分比变化(EAPC)。还调查了 GERD 负担与社会人口指数(SDI)之间的关联。

结果:2019 年,全球有 7.8395 亿例 GERD 患者。1990 年至 2019 年间,总患病例数、新发病例数和 YLD 分别增加了 77.53%、74.79%和 77.19%。在此期间,全球年龄标准化发病率(ASIR)和年龄标准化 YLD 率(ASYR)均有所上升(EAPC 分别为 0.06 和 0.05)。2019 年,热带拉丁美洲和东亚的年龄标准化患病率(ASPR)、ASIR 和 ASYR 最高和最低。1990 年至 2019 年,女性的 GERD 年龄标准化患病率、发病率、YLD 及其相应率均高于男性。在 2019 年,较高的 SDI 与较低的 GERD 的 ASPR、ASIR 和 ASYR 相关。

结论:由于患病例数、新发病例数和 YLD 增加,GERD 将继续成为主要的公共卫生负担。为了解决这个麻烦的疾病,了解全球和区域流行病学和负担趋势的变化对政策制定者和其他利益相关者来说至关重要。

关键信息:这是关于 GERD 全球流行病学的最新估计,包括 204 个国家,其中一些国家以前没有评估过。1990 年,全球 GERD 总负担为 4.4157 亿例,2019 年增至 7.8395 亿例,呈上升趋势。GERD 可能仍然是初级保健中常见的咨询原因,我们的数据可能允许进行卫生服务规划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/973aa44f7ce1/IANN_A_2074535_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/a19e49740ec4/IANN_A_2074535_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/1a5fb28a379c/IANN_A_2074535_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/bdd5c5ac9ac3/IANN_A_2074535_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/1490e17857ac/IANN_A_2074535_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/973aa44f7ce1/IANN_A_2074535_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/a19e49740ec4/IANN_A_2074535_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/1a5fb28a379c/IANN_A_2074535_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/bdd5c5ac9ac3/IANN_A_2074535_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/1490e17857ac/IANN_A_2074535_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/9122392/973aa44f7ce1/IANN_A_2074535_F0005_C.jpg

相似文献

[1]
Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study.

Ann Med. 2022-12

[2]
Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019.

Spine J. 2022-5

[3]
Global, regional, and national burden of incidence, prevalence, and years lived with disability for facial fractures from 1990 to 2019: a systematic analysis for the Global Burden of Disease study 2019.

BMC Oral Health. 2024-4-10

[4]
Epidemiology and burden of pelvic fractures: Results from the Global Burden of Disease Study 2019.

Injury. 2023-2

[5]
Spinal Cord Injury: The Global Incidence, Prevalence, and Disability From the Global Burden of Disease Study 2019.

Spine (Phila Pa 1976). 2022-11-1

[6]
Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the Global Burden of Disease Study 2019.

Clin Rheumatol. 2023-9

[7]
Trends and disparities in disease burden of age-related macular degeneration from 1990 to 2019: Results from the global burden of disease study 2019.

Front Public Health. 2023

[8]
The global burden of traumatic amputation in 204 countries and territories.

Front Public Health. 2023

[9]
Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.

BMC Public Health. 2023-5-19

[10]
Global, regional, and national burden of gallbladder and biliary diseases from 1990 to 2019.

World J Gastrointest Surg. 2023-11-27

引用本文的文献

[1]
Global, regional, and national burden of ischemic heart disease attributable to lead exposure, 1990-2021: decomposition, frontier, and projection analysis.

Front Public Health. 2025-8-18

[2]
Air pollution increases gastroesophageal reflux disease risk: evidence from a prospective cohort study.

Front Public Health. 2025-8-6

[3]
Global burden of chronic kidney disease due to hypertension (1990-2021): a systematic analysis of epidemiological trends, risk factors, and projections to 2036 from the GBD 2021 study.

BMC Nephrol. 2025-8-9

[4]
Association of gastroesophageal reflux disease with the incidence of pulmonary disease.

Front Cell Dev Biol. 2025-7-23

[5]
Multidimensional mechanisms and therapies underlying gastroesophageal reflux disease: focus on immunity, signaling pathways, and the microbiota-gut-brain axis.

Front Immunol. 2025-7-18

[6]
Global, regional, and national burdens of chronic kidney disease attributable to high body mass index from 1990 to 2021, with future forecasts up to 2050: a systematic analysis for the global burden of disease study 2021.

Front Public Health. 2025-7-9

[7]
Global, regional, and national burden of gastroesophageal reflux disease (1990-2021): age-period-cohort analysis and Bayesian projections.

Front Public Health. 2025-7-9

[8]
Causal relationship between gastroesophageal reflux disease and IgA nephropathy: a Mendelian randomization analysis.

Ren Fail. 2025-12

[9]
Global burden of esophageal diseases: a comprehensive analysis of disease trends and risk factors from 1990 to 2021.

BMC Gastroenterol. 2025-7-21

[10]
Association between antibody-mediated immune responses and gastroesophageal reflux disease: Evidence from genetic studies.

Medicine (Baltimore). 2025-7-11

本文引用的文献

[1]
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

Am J Gastroenterol. 2022-1-1

[2]
Current Advancement on the Dynamic Mechanism of Gastroesophageal Reflux Disease.

Int J Biol Sci. 2021

[3]
Gastro-oesophageal reflux disease.

Nat Rev Dis Primers. 2021-7-29

[4]
Gastroesophageal Reflux Disease: A Review.

JAMA. 2020-12-22

[5]
Advances in the diagnosis and management of gastroesophageal reflux disease.

BMJ. 2020-11-23

[6]
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet. 2020-10-17

[7]
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet. 2020-10-17

[8]
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.

Lancet. 2020-10-17

[9]
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet. 2020-8-27

[10]
Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.

J Hematol Oncol. 2020-7-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索